Trial intelligence / Profile preview

BELIEVE: Adalimumab plus calcipotriol/betamethasone vs adalimumab plus vehicle in moderate to severe psoriasis

2007-003073-97Phase 3Completed

Sponsor
Abbott Laboratories
Start
Sep 2007
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Countries
1
01

Overview

Phase 3, randomised trial in plaque psoriasis and psoriasis comparing Adalimumab + calcipotriol/betamethasone with Adalimumab + topical vehicle (2 arms). Primary endpoint: PASI75 response at Week 16. Started Sep 2007; status: completed.

02

Drugs

03

Conditions

plaque psoriasispsoriasis

Beyond the preview

Go deeper on 2007-003073-97.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-003073-97.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call